Breaking News

Tweet TWEET

Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Edwards Lifesciences Corporation

  Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Edwards
  Lifesciences Corporation

Business Wire

LOS ANGELES -- October 11, 2013

The Law Offices of Todd M. Garber announces that a class action lawsuit has
been filed in the United States District Court for the Central District of
California on behalf of a class (the “Class”) comprising all purchasers of the
common stock of Edwards Lifesciences Corporation (“Edwards Lifesciences” or
the “Company”) (NYSE:EW) between April 25, 2012 and April 23, 2013, inclusive
(the “Class Period”).

Edwards Lifesciences is a medical device maker that designs and markets, among
other things, artificial heart valves for implantation in patients with
advanced cardiovascular disease. The Company’s SAPIEN line of transcatheter
heart valves may be implanted using a minimally invasive procedure.

The Complaint alleges that the Company issued false and/or misleading
statements and failed to disclose material facts related to the prospects,
projected sales and adoption of the Company’s Edwards SAPIEN transcatheter
aortic heart valve, including the related transfemoral and transapical
delivery methods (“SAPIEN”), and related projections of financial performance
for the Company’s operations. Specifically, the Complaint alleges that the
defendants knew but concealed from Edwards Lifesciences’ shareholders during
the Class Period that:

  *Adoption of SAPIEN was weaker than the Company claimed, due to concerns
    among physicians over the risks and complexity of the procedure for
    implanting the valve.
  *Edwards Lifesciences’ outlook for sales and earnings per share was
    significantly weaker than the optimistic guidance defendants offered to
    investors.
  *Defendants lacked a reasonable basis for the statements made concerning
    the Company’s operations, forecasts and outlook.

If you are a member of the above-described Class, you may move the Court no
later than November 18, 2013 to serve as lead plaintiff; however, you must
meet certain legal requirements. To be a member of the Class, you may retain
counsel of your choice or take no action and remain an absent member of the
Class. If you have information or would like to learn more about these claims,
or if you purchased Edwards Lifesciences shares prior to the Class Period and
have any questions concerning this announcement or your rights or interests
with respect to these matters, please contact Todd M. Garber, Esquire, of the
Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to
info@toddgarberlaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

Contact:

Law Offices of Todd M. Garber
Todd M. Garber, Attorney at Law
Los Angeles, California
213-700-7262
info@toddgarberlaw.com